Target intelligence / Profile preview

Long intergenic non-protein coding RNA 3133 (LINC03133)

Target
LINC03133
Molecular classification
Long non-coding RNA, lncRNA, intergenic non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 3133 (LINC03133) is a member of the long non-coding RNA (lncRNA) family, specifically categorized as an intergenic lncRNA and is present in the human genome as gene symbol LINC03133[1][3][5]. LINC03133 does not encode a protein; instead, it likely exerts regulatory functions at the transcriptional, post-transcriptional, or epigenetic level, similar to other lincRNAs. Although lincRNAs have been demonstrated to control processes such as chromatin modification, recruitment of histone-modifying complexes, and modulation of gene expression programs[7], there is currently little direct literature that describes LINC03133’s unique molecular activities, biological functions, or disease involvement. Like other lincRNAs, it may act as a molecular scaffold for protein-chromatin interactions or interact with other RNAs or proteins in cell regulatory networks. At present, there is no evidence that LINC03133 serves as a validated therapeutic target, nor are there known drugs or biomarkers specifically linked to it. Most available knowledge is extrapolated from the properties of the lincRNA class and databases that list its genomic identity[1][3][5].

Other names
LINC03133Lnc-CYP7A1-1Lnc CYP7A1-1
02

Biological functions

Regulation of gene expressionmodulation of epigenetic statesmolecular scaffold for chromatin-modifying complexespossible involvement in cell differentiationRNA-protein and RNA-RNA interactions
03

Disease associations

Cancer (by analogy to similar lincRNAs)potentially roles in tumorigenesis, cell differentiation, and epigenetic regulation, although specific associations for LINC03133 are largely uncharacterized in current literature

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 3133 (LINC03133).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 3133 (LINC03133).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call